Skip to product information
1 of 3

Phospho-NF-κB p65 (S529) Recombinant Rabbit mAb (S-1125-59)

Phospho-NF-κB p65 (S529) Recombinant Rabbit mAb (S-1125-59)

Catalog Number: S0B1210 Application: WB, ChIP Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen Phospho-NF-κB p65 (S529)
Synonyms Transcription factor p65; Nuclear factor NF-kappa-B p65 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3; RELA; NFKB3
Immunogen Synthetic Peptide
Location Cytoplasm, Nucleus
Clone Number S-1125-59
Antibody Type Recombinant mAb
Isotype IgG
Application WB, ChIP
Reactivity Hu
Positive Sample HeLa
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
Dot Blot 1:1000
WB 1:1000 Hu
ChIP 1:20-1:50 Hu

Background

Phosphorylation of NF-κB p65 at Ser529 is a post-translational modification that plays a significant role in the regulation of NF-κB activity. This modification is catalyzed by casein kinase II (CK2) upon stimulation by cytokines such as interleukin-1β (IL-1β) or tumor necrosis factor α (TNFα), leading to increased p65 transactivation potential in a gene-specific manner. Phosphorylation at S529 enhances the transcriptional activity of NF-κB, which is crucial for regulating various cellular processes including inflammation, immune responses, and cell survival. Dysregulation of NF-κB signaling, including phosphorylation at S529, has been implicated in various diseases, particularly in the context of chronic inflammation and aging. Phosphorylation of p65 at S529 has also been reported to promote tumorigenesis in various tissues, including the bone, breast, and head and neck, suggesting a significant role of NF-κB phosphorylation in different types of cancers.

Picture

Western Blot

WB result of Phospho-NF-κB p65 (S529) Recombinant Rabbit mAb
Primary antibody: Phospho-NF-κB p65 (S529) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated HeLa whole cell lysate 20 µg
Lane 2: HeLa treated with 20 ng/ml TNF-alpha for 5 miniutes whole cell lysate 20 µg
Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution Predicted MW: 60 kDa
Observed MW: 65 kDa

Dot Blot

Dot blot result of Phospho-NF-κB p65 (S529) Recombinant Rabbit mAb
Lane 1: NF-κB p65 (S529) phospho peptide
Lane 2: NF-κB p65 unmodified peptide
Primary antibody: Phospho-NF-κB p65 (S529) Recombinant Rabbit mAb at 1/1000 dilution
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution

ChIP

Chromatin immunoprecipitation (ChIP) was performed on HeLa+hTNF-α (20 ng/ml, 5 min) cells cross-linked with 1% formaldehyde for 10 min, then chromatin was fragmented by sonication.
Parallel reactions used Phospho NF-κB p65 (S529) Recombinant Rabbit mAb (S-1125-59) and Rabbit mAb IgG Isotype Control (SDT-R173) at 1:50 for immunoprecipitation. Post - immunoprecipitation, both samples were washed, eluted, and cross-links reversed. Purified DNA was analyzed by qPCR.
qPCR showed the enrichment of IL-8 and SAT-α in Phospho-NF-κB
p65 (S529) Recombinant Rabbit mAb (S-1125-59)-immunoprecipitated sample.